Octávio Costa

Nessuna posizione attualmente

Health Technology

Commercial Services

Consumer Services

Profilo

Octávio Costa served as Chief Medical Officer at Cornerstone Pharmaceuticals, Inc. and Monopar Therapeutics, Inc. before earning a doctorate degree from Pontifícia Universidade Católica de São Paulo.

Precedenti posizioni note di Octávio Costa

Società	Posizione	Fine
Cornerstone Pharmaceuticals, Inc. Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ.	Direttore Tecnico/Scientifico/R&S	-
MONOPAR THERAPEUTICS INC.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Octávio Costa

Formazione di Octávio Costa

Pontifícia Universidade Católica de São Paulo

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private